Prosecution Insights
Last updated: October 04, 2026

Soonchunhyang University Industry Academy Cooperation Foundation

Technology area: Biotechnology & Pharmaceuticals

11 pending office actions • 6 art units • 11 examiners • 0 of 11 (0%) have an AI response strategy ready • 2 patents granted in the last 365 days

Analysis

Soonchunhyang University Industry Academy Cooperation Foundation has 10 pending office actions in the Biotechnology & Pharmaceuticals technology area. Each of these 10 actions is assigned to a different person, resulting in 10 distinct examiners for the portfolio. These matters are spread across 6 distinct art units, which indicates that the foundation's biotech and pharma work is reviewed by several different technical groups at the USPTO. The distribution across 6 distinct art units suggests that the 10 pending office actions cover a variety of specific biotechnology or pharmaceutical applications.

Jason S Uhlenhake is the busiest examiner for the portfolio with 1 pending office action. Because there are 10 distinct examiners for the 10 total actions, there is no overlap in examiner assignments. The 6 distinct art units involved show that the 10 pending office actions are distributed across multiple specialized units. This structure requires the foundation to navigate 10 different individual examination styles. Practitioners should develop unique strategies for each of the 10 pending office actions to address the specific feedback from each assigned examiner within the Biotechnology & Pharmaceuticals sector.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

11
Total Pending OAs
7
Non-Final OAs
4
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 3 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

0
Overdue
0
Due this week
1
Due this month
1
Due in next 60 days
1
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 3 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Due ≤ 30 days (1)Due ≤ 60 days (1)Due later (1)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

9
Hard (82%)
2
Medium (18%)
0
Easy (0%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§101 + other2 (18%)
§103 only2 (18%)
Multi-statute (no §101)7 (64%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

5
Life Sciences
45% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
1
Semiconductors
9% of docket
1
Mechanical / Eng
9% of docket
4
Business / Other
36% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

110 h
Manual time on pending OAs
22 h
Time saved (low, 20%)
38 h
Time saved (mid, 35%)
1.0 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
UHLENHAKE, JASON S 1 87.3% -2.3%
NEAGU, IRINA 1 46.8% +57.3%
YOON, CHANEL J 1 55.0% +40.1%
FIDLER, SHELBY LEE 1 79.1% +14.2%
SCHLOOP, ALLISON ELIZABETH 1 63.0% +56.5%
CHUNDURU, SURYAPRABHA 1 53.3% +17.8%
WRIGHT, AMIRAH DANNYE 1 — —
KOHUTKA, BROOKE NICOLE 1 37.5% +92.3%
BAUSCH, SARAE L 1 29.8% +44.7%
EVANS, CHRISTOPHER RYAN 1 60.9% +64.3%

Hard Cases (9)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
18039563 PCR KIT FOR DIAGNOSING ASTHMA OR ASTHMA EXACERBATION AND METHOD FOR PROVIDING INFORMATION FOR DIAGNOSING ASTHMA OR ASTHMA EXACERBATION BY USING SAME BAUSCH, SARAE L 33d
19180156 INKJET HEAD MONITORING SYSTEM AND METHOD UHLENHAKE, JASON S —
19032593 PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING NEOPLASTIC DISORDERS COMPRISING AURANOFIN AS AN ACTIVE INGREDIENT NEAGU, IRINA —
18833553 MICROBIOME COLLECTION DEVICE YOON, CHANEL J —
18584279 METHOD FOR DETECTING TARGET NUCLEIC ACIDS USING PLASMONIC IMMUNOMAGNETIC NANOPARTICLES SCHLOOP, ALLISON ELIZABETH —
18583776 RAPID TARGET GENE DETECTION METHOD USING PLASMONIC PHOTOTHERMAL REACTION CHUNDURU, SURYAPRABHA —
18420939 APPARATUS FOR ASSISTING ACTIVE MOTION OF FINGER WRIGHT, AMIRAH DANNYE —
18284017 SLEEVE GASTRECTOMY AID DEVICE KOHUTKA, BROOKE NICOLE —

Interview Candidates (8)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
18039563 PCR KIT FOR DIAGNOSING ASTHMA OR ASTHMA EXACERBATION AND METHOD FOR PROVIDING INFORMATION FOR DIAGNOSING ASTHMA OR ASTHMA EXACERBATION BY USING SAME BAUSCH, SARAE L 33d
18666247 INKJET PRINTING SYSTEM FIDLER, SHELBY LEE 71d
19032593 PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING NEOPLASTIC DISORDERS COMPRISING AURANOFIN AS AN ACTIVE INGREDIENT NEAGU, IRINA —
18833553 MICROBIOME COLLECTION DEVICE YOON, CHANEL J —
18584279 METHOD FOR DETECTING TARGET NUCLEIC ACIDS USING PLASMONIC IMMUNOMAGNETIC NANOPARTICLES SCHLOOP, ALLISON ELIZABETH —
18583776 RAPID TARGET GENE DETECTION METHOD USING PLASMONIC PHOTOTHERMAL REACTION CHUNDURU, SURYAPRABHA —
18284017 SLEEVE GASTRECTOMY AID DEVICE KOHUTKA, BROOKE NICOLE —
17907432 COMPOSITION USING URINE SAMPLE FOR DIAGNOSIS OF KIDNEY DISEASE EVANS, CHRISTOPHER RYAN —

Top Art Units

Art UnitApps
1629 2
2853 1
1672 1
3791 1
1699 1
1677 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
19180156 INKJET HEAD MONITORING SYSTEM AND METHOD UHLENHAKE, JASON S — §102§103 Non-Final OA — Pending Apr 16, 2025
19032593 PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING NEOPLASTIC DISORDERS COMPRISING AURANOFIN AS AN ACTIVE INGREDIENT NEAGU, IRINA 1629 §102§103 Non-Final OA — Pending Jan 21, 2025
18833553 MICROBIOME COLLECTION DEVICE YOON, CHANEL J — §102§112 Final Rejection — Pending Jul 26, 2024
18666247 INKJET PRINTING SYSTEM FIDLER, SHELBY LEE 2853 §103 Final Rejection 71d Pending May 16, 2024
18584279 METHOD FOR DETECTING TARGET NUCLEIC ACIDS USING PLASMONIC IMMUNOMAGNETIC NANOPARTICLES SCHLOOP, ALLISON ELIZABETH — §103§112 Non-Final OA — Pending Feb 22, 2024
18583776 RAPID TARGET GENE DETECTION METHOD USING PLASMONIC PHOTOTHERMAL REACTION CHUNDURU, SURYAPRABHA 1672 §103§112 Non-Final OA — Pending Feb 21, 2024
18420939 APPARATUS FOR ASSISTING ACTIVE MOTION OF FINGER WRIGHT, AMIRAH DANNYE — §103§112 Non-Final OA — Pending Jan 24, 2024
18284017 SLEEVE GASTRECTOMY AID DEVICE KOHUTKA, BROOKE NICOLE 3791 §102§103§112 Final Rejection — Pending Sep 25, 2023
18039563 PCR KIT FOR DIAGNOSING ASTHMA OR ASTHMA EXACERBATION AND METHOD FOR PROVIDING INFORMATION FOR DIAGNOSING ASTHMA OR ASTHMA EXACERBATION BY USING SAME BAUSCH, SARAE L 1699 §101§102§103§112 Non-Final OA 33d Pending May 31, 2023
17907432 COMPOSITION USING URINE SAMPLE FOR DIAGNOSIS OF KIDNEY DISEASE EVANS, CHRISTOPHER RYAN 1677 §101§103 Non-Final OA — Pending Sep 27, 2022
17744162 USE OF SILDENAFIL AND ROCK INHIBITORS FOR TREATING STROKE OR SEQUELAE FOLLOWING STROKE SCHMITT, MICHAEL J 1629 §103 Final Rejection 30d Pending May 13, 2022

Managing Soonchunhyang University Industry Academy Cooperation Foundation's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month